Novavax Inc at Evercore ISI HealthCONx Virtual Conference Transcript
All right. Welcome, everyone. For your next session with Novavax, we have Filip Dubovsky, Chief Medical Officer; and John Trizzino, Chief Commercial Officer and Chief Business Officer. Gentlemen, welcome, and thank you for your efforts in a COVID pandemic to develop one of the more advanced vaccines.
So why don't we dig in and give us a quick snapshot of where we are with the Novavax COVID vaccine?
Questions & Answers
Yes. So let me kick off, Josh. I think we're at a point in time where we're feeling more confident than ever about where we are from getting to approval. We, over the last several weeks, have made regulatory submissions to the EU, UK, Canada, Australia and a variety of others that on a harmonized regulatory submission, that allow us to be able to move very quickly. We're in the process now of coordinating with the various
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
